Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 2/20 | 0.43 |
| ▸ | RXRB | P28702 | 2/20 | 0.43 |
| ▸ | SERPINE1 | P05121 | 2/20 | 0.41 |
| ▸ | KIF11 | P52732 | 1/20 | 0.40 |
| ▸ | PTAFR | P25105 | 1/20 | 0.38 |
| ▸ | DHODH | Q02127 | 1/20 | 0.34 |
| ▸ | DNMT1 | P26358 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 2/20 | 0.33 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26530671 | 0.96 | SERPINE1 (0.43) | RXRARXRBSERPINE1KIF11PTAFR | |
| SCHEMBL26529275 | 0.93 | RXRB (0.40) | RXRARXRBSERPINE1KIF11DHODH | |
| SCHEMBL26528737 | 0.92 | RXRB (0.41) | RXRARXRBSERPINE1KIF11DNMT1 | |
| SCHEMBL26529470 | 0.91 | RXRB (0.39) | RXRARXRBSERPINE1DHODHDNMT1 | |
| SCHEMBL26529280 | 0.91 | DHODH (0.40) | RXRARXRBSERPINE1KIF11DHODH | |
| SCHEMBL26529513 | 0.90 | RXRB (0.40) | RXRARXRBSERPINE1KIF11DHODH | |
| SCHEMBL26529472 | 0.90 | RXRB (0.40) | RXRARXRBSERPINE1KIF11DHODH | |
| SCHEMBL26529404 | 0.89 | KIF11 (0.38) | RXRARXRBSERPINE1KIF11PTAFR | |
| SCHEMBL26529486 | 0.88 | RXRB (0.39) | RXRARXRBSERPINE1DHODHDNMT1 | |
| SCHEMBL26529467 | 0.88 | RXRB (0.36) | RXRARXRBSERPINE1KIF11PTAFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230329101-A1 | Organic Light Emitting Compound And Organic Light Emitting Device Including Same | P&h Tech Co., Ltd. (KR) | 2023-10-12 | — | — | US | disclosed |
| US-20230329101-A1 | Organic Light Emitting Compound And Organic Light Emitting Device Including Same | P&h Tech Co., Ltd. (KR) | 2023-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230329101-A1 | Organic Light Emitting Compound And Organic Light Emitting Device Including Same | ORMDL3, OR10J3, ORC3 | RXRA 1633/4885RXRB 2498/4885SERPINE1 4578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.